Ignite Creation Date:
2024-05-05 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00423202
Status:
COMPLETED
Last Update Posted:
2009-04-16
First Post:
2007-01-17
Brief Title:
A Phase 3 Randomized Double-Blind Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Organization Data
Organization:
Gilead Sciences
Class:
INDUSTRY
Study ID:
AMB-321
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gilead Sciences
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None